...
首页> 外文期刊>Progres en urologie: journal de l’Association francaise d’urologie et de la Societefrancaise d’urologie >Sub-urethral sling Advance? midterm results: Patient selection and predictors of success [Bandelette sous-urétrale Advance?: Résultats à moyen terme: Sélection des patients et facteurs prédictifs]
【24h】

Sub-urethral sling Advance? midterm results: Patient selection and predictors of success [Bandelette sous-urétrale Advance?: Résultats à moyen terme: Sélection des patients et facteurs prédictifs]

机译:尿道下吊带前进吗?中期结果:患者选择和成功的预测因素[尿道下带进展?:中期结果:患者选择和预测因素]

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction and objectives: Sub-urethral trans-obturator male slings have been propose to treat men urinary incontinence. Medium term results are lacking: only one study has been published. Aim: To evaluate the efficacy of the sub-urethral sling Advance? (American Medical System, Minnetonka, MN, USA) and determinate factor of success. Materials and methods: Single center retrospective study of patients implanted with an Advance? for urinary incontinence after radical prostatectomy. The degree of incontinence was evaluated by number of pads used per days: mild (use of 1 to 2pads/day), moderate (3 to 4p/day) and severe (≥5p/day). The "Cure" was defined as no pad or just one for "security reason" and "improved" as decreased more than 50% of pads use. Results: Between October 2007 and November 2009, 69slings were implanted. Mean follow-up was 32.4months (±8.4months). Before treatment, 37.68% of the patients suffered from mild, 42.03% moderate and 20.29% severe urinary incontinence. At midterm, 21.8% of the patients were cured and 50.7% cured or improved. For patients who suffered from mild or moderate urinary incontinence, 23.6% were cured and 58.2% were cured or improved. The cure rate decreased with the severity of incontinence. It was respectively 30.8%, 17.2% and 14.2% for mild, moderate and severe incontinence. Failure rate was more important with severe incontinence: 78%. For patients with urethral fence pressure less than 57cmH2O, the risk of failure was multiply by 6.6. No severe complication was noted during follow-up. Only one male sling was removed. Conclusions: At midterm, one patient on five was cure and half was cured or improved. The technique presented an acceptable morbidity and a good tolerance. Two predictors of success were identified: severity of incontinence and residual sphincter function. Good candidates used less than three pads per day.
机译:引言和目的:提出了经尿道下闭孔的男性吊带治疗男性尿失禁。缺乏中期结果:仅发表了一项研究。目的:评估尿道下吊带的疗效吗? (美国医疗系统,美国明尼苏达州Minnetonka)和成功的决定因素。材料和方法:单中心回顾性研究患者是否植入了Advance?用于前列腺癌根治术后尿失禁的治疗。失禁程度通过每天使用的护垫数量进行评估:轻度(每天使用1至2个护垫),中度(每天3至4p)和严重(≥5p)。 “治愈”被定义为无护垫或出于“安全原因”仅一种护垫,而“改善”则定义为减少了超过50%的护垫使用。结果:从2007年10月到2009年11月,植入了69根吊索。平均随访32.4个月(±8.4个月)。治疗前,有37.68%的患者患有轻度尿失禁,42.03%的中度尿失禁和20.29%的严重尿失禁。中期时,治愈的患者占21.8%,治愈或改善的患者占50.7%。对于患有轻度或中度尿失禁的患者,治愈率为23.6%,治愈或改善为58.2%。随着失禁的严重程度治愈率下降。轻度,中度和重度尿失禁分别为30.8%,17.2%和14.2%。严重失禁的失败率更为重要:78%。对于尿道围栏压力低于57cmH2O的患者,失败的风险乘以6.6。随访期间未发现严重并发症。仅移除了一个雄性吊索。结论:在中期,五名病人中的一名治愈,一半或治愈或好转。该技术具有可接受的发病率和良好的耐受性。确定了两个成功的预测因素:大小便失禁和括约肌功能残留。好的候选人每天使用少于三个便笺簿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号